It is used as adjunct therapy with Levodopa and carbidopa in the symptomatic treatment of PD.366 Ropinirole is a non-ergoline dopamine agonist, approved as monotherapy and as an adjunct to Levodopa in the treatment of PD.367 Benztropine is used to treat the molecular mechanism of anticholinergic...
Pincus that investigated the use of the protein redistribution diet in forty-three carbidopa-levodopa-treated parkinsonian patients with protein-sensitive motor fluctuations. Study methods and results; Prolonging the efficacy of levodopa therapy in fluctuating 'end-stage' patients.Smith...
The disease progression is similar for both early- and late-onset Alzheimer’s disease and is arbitrarily split into three overlapping stages: early/mild, moderate, and severe. The initial onset of Alzheimer’s disease is insidious, with memory loss the earliest and most frequently cited symptom....
Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with “wearing-off” phenomenon: a multicentre, double-blind, randomized,... To assess the effect of tolcapone added to levodopa plus benserazide or carbidopa on the “wearing-off” phenomenon in patients with Parkin...
On a nearly zero protein diet, 11 patients with Parkinson's disease with the "on-off" effect demonstrated great sensitivity to levodopa (L-dopa)-carbidopa ... J H,Pincus,Barry - 《Archives of Neurology》 被引量: 162发表: 1987年 An ATP-site on-off switch that restricts phosphatase accessi...
Until 11 years of age he was described as neurologically healthy; he then developed a gait disturbance and pain in the lower limbs. After 2 years, the symptoms spread, causing a swallowing disturbance. He was placed on medication (biperiden up to 24 mg daily and levodopa/carbidopa 125 mg/...
L-Dopa suppressed resting levels of vasopressin and inhibited the rise of vasopressin produced by head-up tilt. Carbidopa, a decarboxylase inhibitor that does not cross the blood-brain barrier blocked the action of L-Dopa. These results suggest that dopamine inhibits the release of vasopressin, ...
Until 11 years of age he was described as neurologically healthy; he then developed a gait disturbance and pain in the lower limbs. After 2 years, the symptoms spread, causing a swallowing disturbance. He was placed on medication (biperiden up to 24 mg daily and levodopa/carbidopa 125 mg/...
Drugs for Parkinson's disease, spasticity, and acute muscle spasms such as levodopa, carbidopa, amantadine, apomorphine, bromocriptine, selegiline (deprenyl), trihexyphenidyl hydrochloride, benztropine mesylate, procyclidine hydrochloride, baclofen, diazepam, dantrolene and the like. Respiratory agents such ...
Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with “wearing-off” phenomenon: a multicentre, double-blind, randomized,... To assess the effect of tolcapone added to levodopa plus benserazide or carbidopa on the “wearing-off” phenomenon in patients with Parkin...